Chemical in Broccoli Blocks Growth of Prostate Cancer Cells, New Study Shows
Men and those who love them have even more reason to keep up pressure for healthy diets. Researchers at the University of California, Berkeley report that a chemical produced when digesting such greens as broccoli and kale can stifle the growth of human prostate cancer cells. Similar benefits popped up earlier for breast cancer.
The latest findings show that 3,3'-diindolylmethane (DIM), which is obtained by eating cruciferous vegetables in the Brassica genus, acts as a powerful anti-androgen that inhibits the proliferation of human prostate cancer cells in culture tests. The effect is comparable to that of a standard prostate cancer therapy, Casodex, which blocks cancer-promoting effects of circulating male hormone.
"As far as we know, this is the first plant-derived chemical discovered that acts as an anti-androgen," said Leonard Bjeldanes, professor and chair of nutritional sciences and toxicology at UC Berkeley's College of Natural Resources and principal investigator of the study. "This is of considerable interest in the development of therapeutics and preventive agents for prostate cancer."
Vegetables such as broccoli, Brussels sprouts, kale and cauliflower are rich sources of indole-3-carbinol (I3C), which the body converts into DIM during digestion. Over the years, Bjeldanes has been researching the anti-cancer properties of dietary indoles with co-author Gary Firestone, UC Berkeley professor of molecular and cell biology. The latest study was published in the June 6, 2003 issue of the Journal of Biological Chemistry, available online.
Androgens are a class of male hormone important for the normal development and function of the prostate, but they also play a key role in the early stages of prostate cancer, which is typically treated with anti-androgen drugs.
In most cases of prostate cancer, the cancer cells develop resistance to androgen and grow independently of the hormone in later stages of the disease.
In the new study, the researchers conducted a series of tests comparing the effects of DIM on androgen-dependent human prostate cancer cells as well as on their androgen-independent counterparts.
They found that androgen-dependent cancer cells treated with a solution of DIM grew 70 percent less than the same type of cancer cells that had been left untreated. The same solution had no effect on the growth of androgen-independent cells, pointing to androgen inhibition as the key mechanism by which the DIM is acting.
This was confirmed with further tests showing that DIM inhibits the actions of dihydrotestosterone (DHT), the primary androgen involved in prostate cancer. DHT stimulates the expression of prostate specific antigen (PSA), which acts as a growth factor for prostate cancer. When androgen-dependent cells were treated with DIM, the researchers found a drop in the level of PSA.
"There are lots of things that can stop growth, but the fact that DIM decreases the expression of PSA shows that it is functioning at a gene expression level," said Bjeldanes.
One possible contributor to the lower prostate cancer rates in Asian men is the higher consumption of phytochemical-rich vegetables that is typical of this population. Consumption of cruciferous vegetables, including broccoli, Brussels sprouts, kale, and cauliflower, has been associated with a decreased risk of various human cancers. The strongest associations are with cancers of the breast, endometrium, colon, and prostate.
Comparisons of the molecular conformation of DIM show that it is similar to Casodex, a synthetic anti-androgen on the market. "DIM works by binding to the same receptor that DHT uses, so it's essentially blocking the androgen from triggering the growth of the cancer cells," said Hien Le, lead author of the study and a former graduate student in Bjeldanes' lab.
"DIM is chemically different than Casodex, but it behaves similarly in how it blocks the effects of androgen," said Le, who received her PhD in molecular and biochemical nutrition in 2002.
These latest findings appear to add new burnish for this class of chemicals that has already shown promise in prior studies as a therapeutic agent for breast and endometrial cancer. For instance, a 1998 study by Bjeldanes and Firestone showed that I3C keeps breast cancer cells from duplicating.
"We are investigating the potential use of indoles in combination with current anti-cancer drugs on the market," said Firestone. "The advantage of combination therapy is that you can back off on the dose of a single agent and thereby reduce potential side effects."
Prostate cancer is the second leading cause of cancer deaths in American men. One in 10 men in the United States will develop signs of prostate cancer in his life, and more than 100,000 new cases are reported each year.
Le pointed out that the incidence of prostate cancer among men in Asia - where consumption of vegetables is higher - is significantly lower than that for men in the United States. However, the risk for Asian immigrants rises to levels comparable to American men the longer they stay in the United States, suggesting that factors such as diet and lifestyle play a role in the development of prostate cancer.
"There are already plenty of health reasons for consuming more vegetables such as broccoli," said Le. "This study suggests that there are even more benefits to a diet rich in these phytochemicals when it comes to preventing prostate cancer."
The study was also co-authored by Charlene Schaldach, a former PhD student in the Bjeldanes lab.
The research is supported by the California Cancer Research Project and the National Institute of Environmental Health Sciences, part of the National Institutes of Health.
Leonard Bjeldanes at Berkeley. He has done similar studies of effect of indoles on breast cancer cells.
Plant-derived 3,3'-Diindolylmethane Is a Strong Androgen Antagonist in Human Prostate Cancer Cells (full text, free)
Hien T. Le , Charlene M. Schaldach , Gary L. Firestone and Leonard F. Bjeldanes . From the Department of Nutritional Sciences and Toxicology and Department of Molecular and Cell Biology, The University of California, Berkeley, CA and Lawrence Livermore National Laboratory, Livermore, CA
Update: cancer patients' friends and foes: Food Manufacturers Oppose Trans Fat Consumer Information on Labels (Oct 9, 20003)
Green Tea's Cancer Fighting Allure becomes More Potent (August 5 2003).
Farmed Salmon High in PCBs Aug 2003
Ocean Salmon Dump PCBs in Spawning Waters Nature, 18 September 2003.
Eating Fatty Fish May Slash Risk Of Prostate Cancer June, 2001, Eating fatty fish like salmon, sardines, herring and mackerel could reduce the risk of prostate cancer by a third, according to a report in June 2 issue of The Lancet.
Super-Broccoli Bred to Fight CancerMay 25 2000. This cross between garden broccoli and a wild Sicilian variety is the latest veggie to hold out anti-cancer promise. The team that developed super-broccoli at the John Innes Centre at the Institute of Food Research in Norwich, England now have two commercial partners. Full story
Heart-Healthy Soy Labels May Help Prostate Cancer Survivors Men dealing with prostate cancer and people concerned about heart disease may be interested in eating soy foods -- but they discourage treating soy as a medicine or drug.
This page created Jan 16, 2004. Ed. J. Strax.